Overinvested in CSL? Here are two alternative ASX healthcare stocks

I think these two stocks are healthy investment options.

| More on:
Two lab workers fist pump each other.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX healthcare stock CSL Ltd (ASX: CSL) is one of the most impressive businesses on the ASX with how it grew from a relatively small business into the global giant it is today.

However, long-term shareholders may find themselves significantly allocated to the business because of its share price growth over the years. What are investors supposed to do about that?

I can understand if shareholders want to stay invested, but perhaps gaining exposure to the ASX healthcare sector through additional businesses could be a good diversification strategy.

I'm going to talk about two businesses that offer generalised exposure to the healthcare sector rather than being focused on one medical condition or one type of treatment.

Sonic Healthcare Ltd (ASX: SHL)

Sonic Healthcare is a pathology business with global operations. It has a presence in countries such as Australia, New Zealand, the UK, Germany, Switzerland, and the USA.

It provides an essential part of the healthcare journey so that patients can get the right treatment.

I believe this business offers defensive earnings because demand is always there – people continue to get sick regardless of the economy. Indeed, long-term demand is increasing in countries with growing and ageing populations, helping drive Sonic Healthcare's organic revenue.

The ASX healthcare stock is also regularly making acquisitions to boost its presence and scale. European acquisitions have been a focus in the last couple of years.

Sonic Healthcare is investing money and effort into artificial intelligence, which could help it lower costs and serve customers.

I think the long-term looks very promising for this business if its revenue and margins increase.

NIB Holdings Limited (ASX: NHF)

NIB is one of the largest private health insurers in Australia. Following the 25% decline in its share price in the last six months, as shown on the chart below, it looks much better value to me.

Created with Highcharts 11.4.3NIB Holdings PriceZoom1M3M6MYTD1Y5Y10YALL2 Jun 20242 Dec 2024Zoom ▾Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24Jul '24Jul '24Sep '24Sep '24Nov '24Nov '24www.fool.com.au

The business generates earnings in a variety of different ways, such as its core Australian resident health insurance business, the international students and workers segment and an NDIS business.

The ASX healthcare stock is in a challenging environment. Private health providers such as hospitals are facing difficulties, while the government and private health insurers are being asked for increased funding.

I don't know how this will be resolved, but I do believe this pessimistic period is a good time to be looking at NIB shares while there is pain in the sector.

NIB continues to win new policyholders, which provides scale benefits and is a tailwind for profitability. In FY25 to October 2024, its number of Australian resident health insurance policyholders had increased by a further 3.2% to 728,901.

This is not a simple turnaround, but I think the NIB share price decline reflects the difficulties and provides an opportunity for brave investors.

Motley Fool contributor Tristan Harrison has positions in Sonic Healthcare. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool Australia has recommended CSL and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Healthcare Shares

Down 15% since January, are Cochlear shares now a buy?

Let's see what analysts are saying about this blue chip.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Healthcare Shares

Guess which popular ASX 200 stock is up nearly 60% in less than 2 months?

Investors who bought this ASX 200 stock in the recent dip have been strongly rewarded.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Are Sigma Healthcare shares a good buy now after the merger with Chemist Warehouse?

Sigma Healthcare shares have soared 154% in 12 months. Can this stellar run continue?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Up 34% since April, ASX 300 healthcare stock lifts off again today on new milestone

The ASX 300 healthcare stock has been on a tear since hitting one-year lows in April.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should I buy the dip on CSL shares?

A leading fund manager gives his verdict on the growth prospects for CSL shares.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Healthcare Shares

NIB shares have soared 24% this year. Does Macquarie expect this to continue?

Will this private health insurer continue to deliver big returns? Let's find out.

Read more »

Woman presenting financial report on large screen in conference room.
Healthcare Shares

Up nearly 30% in a year, should I buy Fisher & Paykel shares before its earnings result?

Will the ASX 200 healthcare stock continue to outperform?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL shares among most expensive on ASX. Is now a good time to buy?

Analysts predict CSL share price growth will keep on coming.

Read more »